PTCT PTC Therapeutics, Inc.
$62.09▲ +1.67%
Healthcare
Other
Pre-market
$62.09▲ +0.00%
Oct 28, 4:04 AM ET
Volume 1.11M
Avg Volume (10D) 939.0K
Key Metrics & Fundamentals
Market Cap
$5.18B
P/E Ratio
–
Div Yield
0.00%
52W Range
58.80 - 90.87
% vs 50 MA
-5.85%
% vs 200 MA
-12.41%
RSI-14
46.2
MACD Histogram
+0.2600
Beta (1Y vs SPY)
0.72
Free Cash Flow
$121.97M
Gross Rev
$360.52M
Gross Profit
$340.60M
EBITDA
$161.90M
COGS
$19.92M
Operating Exp
$191.62M
Operating Income
$148.98M
EBIT
$148.98M
Pretax Income
$97.55M
Net Income
$83.50M
EPS (Diluted)
0.92
Price & Volume History
Loading chart…
Recent News
Liquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy?
Zacks · Oct 26, 2026 9:00 AM ET
Analysts Estimate PTC Therapeutics (PTCT) to Report a Decline in Earnings: What to Look Out for
Zacks · Oct 22, 2026 9:00 AM ET
UBS Adjusts Price Target on PTC Therapeutics to $90 From $80, Maintains Buy Rating
MT Newswires · Oct 15, 2026 10:49 AM ET
PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026
PR Newswire · Oct 15, 2026 8:00 AM ET
RBC Cuts Price Target on PTC Therapeutics to $75 From $85, Keeps Sector Perform Rating
MT Newswires · Oct 8, 2026 7:19 AM ET
PTC Therapeutics Retains Significant Firepower for Bolt-On Deals, RBC Capital Markets Says
MT Newswires · Oct 7, 2026 11:22 AM ET
Is PTC Stock Increasing Your Market Risk?
Trefis · Oct 6, 2026 8:30 AM ET
Which Gives You More Of Hard-To-Replace Software, PTC Or Fair Isaac?
Trefis · Sep 30, 2026 11:17 AM ET
2026 Philadelphia ORBIE Awards Honor Top Technology and Security Executives in Philadelphia
GlobeNewswire · Sep 28, 2026 11:02 AM ET
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire · Sep 25, 2026 4:30 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PTCT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.